FRG Family Wealth Advisors’s Biogen BIIB Stock Holding History

FRG Family Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33	Closed	-$7.09K	–	169
2024 Q1	$7.09K	Buy	+33	New	+$7.73K	﹤0.01%	285

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FRG Family Wealth Advisors's BIIB Position: Q2 2024 in Review

FRG Family Wealth Advisors sold out of Biogen (BIIB) in Q2 2024, closing a stake of 33 shares — an estimated $7.09K sold.

FRG Family Wealth Advisors first reported a position in BIIB in Q1 2024 and held it in 1 quarter. The position peaked at $7.09K in Q1 2024. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

FRG Family Wealth Advisors reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
FRG Family Wealth Advisors sold 33 Biogen shares in Q2 2024, an estimated $7.09K.
FRG Family Wealth Advisors first reported a position in Biogen in Q1 2024 and held it in 1 quarter.
FRG Family Wealth Advisors's Biogen position peaked at $7.09K in Q1 2024.
943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on FRG Family Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.